The Institute of Bioorganic Chemistry offers consumers the PRODOSCREEN® IFA-AFLATOXIN M1 enzyme-linked immunosorbent assay kit for the determination of aflatoxin M1 in milk and dairy products (including baby food) using competitive enzyme-linked immunosorbent assay under a manufacturing agreement, services for developing test systems for the needs of the food and medical industries under an outsourcing agreement, and is looking for partners to conclude a distribution services agreement.

Enzyme-linked immunosorbent assay (ELISA) kits for the detection of aflatoxin M1 in milk and dairy products, including infant formula, are used for food quality and safety monitoring. These kits enable rapid and accurate detection of the toxin even at low concentrations, which is particularly important for protecting consumer health.

Major global manufacturers of enzyme-linked immunosorbent assay (ELISA) kits for aflatoxin M1:

1. R-Biopharm AG (Germany)
- Features: One of the leading manufacturers of food testing kits, including ELISA kits for aflatoxin M1.
2. Neogen Corporation (USA)
- Features: Manufacturer of food safety testing kits, including aflatoxin M1 test kits.
3. Eurofins Technologies (Europe)
- Features: The company offers a wide range of ELISA kits for food testing, including aflatoxin M1.
4. Romer Labs (Austria)
- Special Features: Manufacturer of mycotoxin analysis solutions, including kits for the detection of aflatoxin M1 in dairy products.
5. Shenzhen Lvshiyuan Biotechnology Co., Ltd. (China)
- Special Features: Manufacturer of diagnostic kits for food analysis, including tests for aflatoxin M1.

The Institute of Bioorganic Chemistry has developed the PRODOSCREEN® IFA-Aflatoxin M1 reagent kit (TU BY 100185129.201-2023) for the detection of aflatoxin M1 in milk and dairy products (including baby food) using competitive enzyme-linked immunosorbent assay.

The information is published in the Catalog "100 Best Developments of the National Academy of Sciences of Belarus for the National Economy in 2022–2023," pp. 130–131.

Technical advantages (compared to the best domestic and foreign analogues):

- state-of-the-art scientific and technical standards, expanded range of analyzed products, simplified sample preparation, improved performance properties, proprietary production technology, and cost halved.

Production Ready:
The development is ready for production use.

The Institute of Bioorganic Chemistry of the National Academy of Sciences of Belarus is the copyright holder of the PRODOSKRIN® trademark in the Republic of Belarus and the Russian Federation. "Komprodservis LLC" has the right to use the PRODOSKRIN® trademark in the Republic of Belarus and the Russian Federation, granted under license agreements.

Currently, the Institute of Bioorganic Chemistry of the National Academy of Sciences of Belarus is the leading research center in the Republic of Belarus and one of the most renowned international centers for the study of key biopolymers (proteins, enzymes, nucleic acids) and low-molecular-weight bioregulators (human, insect, and plant steroid hormones, peptides, phospholipids, prostaglandins, and their synthetic analogs).

Main areas of activity:
- Fundamental and applied research in the chemistry, structure, and function of biopolymers and low-molecular-weight bioregulators, including proteins, nucleic acids and their components, phospholipids, steroids, prostaglandins, brassinosteroids, and ecdysteroids;
- Development and pilot production of immunochemical and molecular biological reagent kits for medical and veterinary diagnostics;
- Development and production of pharmaceutical substances, hormonal preparations, and biospecific hemosorbents;
- Development of technologies for the production and use of growth stimulants and plant protection products;
- Experimental and clinical pharmacology, pharmacy and drug technology, toxicology, human and animal biochemistry, biomedical and pharmaceutical chemistry;
- Preclinical, bioequivalence, and pharmaceutical testing.

Main research areas:
- Organic and bioorganic chemistry of low-molecular-weight bioregulators (steroids, peptides, prostaglandins, lipids, nucleosides, and nucleotides) and key biopolymers, including proteins and nucleic acids, and the elucidation of their functioning in living systems;
- Development of new chemical, chemical-enzymatic, and genetic engineering methods for producing biopolymers and low-molecular-weight bioregulators and their analogs for the development of pharmaceuticals for medicine and agriculture;
- Study of the structure, physicochemical properties, and biological activity of natural biomolecules and their analogs, establishing the relationship between their structure and biological activity, and developing scientific principles for the targeted search for substances with predictable biological activity. - study of the structure, function, and mechanism of action of enzyme systems involved in the biosynthesis and metabolism of key natural bioregulators and xenobiotics;
- development of technologies for the production of reagents for medical diagnostics, pharmaceuticals, and plant protection chemicals.

The institute has experimental facilities for studying the biological activity of the resulting compounds at the cellular level and in animal models. Five pilot production sites have been established at the institute for pilot production of the developed products (hemosorbents, recombinant enzyme preparations, immunochemical reagents, oxyphytosterols, etc.).

The results of fundamental and applied research on methods and means for protecting plants from diseases, insects, weeds, and other adverse environmental factors that are safe for humans and the biosphere as a whole have formed the foundation for the development of new plant growth stimulants, pheromone compositions (codling moth LP-U and miller moth pheromones), active pesticide ingredients, and pesticide formulations (herbicides, insecticides, fungicides, etc.).

The institute's intellectual property currently consists of valid patents, laboratory process and pilot industrial regulations, technical specifications, and trademarks. License agreements are in place for the transfer of technologies for the production of immunodiagnostic products, hemosorbents, and pesticides to manufacturers.

The Institute of Bioorganic Chemistry is successfully developing international ties in its core research areas. The institute currently conducts joint research with research institutes in the CIS countries, Germany, the USA, Canada, Sweden, Finland, Denmark, the Netherlands, Vietnam, and other countries.

Official website of the Institute of Bioorganic Chemistry.